Skip to main content
JETEMA Co.,Ltd. logo

JETEMA Co.,Ltd. — Investor Relations & Filings

Ticker · 216080 ISIN · KR7216080002 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 216080

About JETEMA Co.,Ltd.

http://www.jetema.com/

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1, 2026 to March 31, 2026, filed with the Financial Supervisory Service and Korea Exchange. It contains detailed financial data, company overview, business description, capital changes, product revenues, and other substantive report items typical of an interim/quarterly report. It is not merely an announcement or summary, but the full interim report itself. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 86% confidence The document is a Korean regulatory disclosure (“주식매수선택권 부여에 관한 신고”) correcting a prior filing on the grant of stock options to directors and employees. It details changes in number of options granted, exercise conditions, and related capital references. This is not an earnings release, management discussion, or annual report, but a notification of a capital change (stock option issuance). Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-13 Korean
주식등의대량보유상황보고서(약식)
Regulatory Filings
2026-05-08 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-05-08 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a brief announcement about a change in the company's department affiliation (from 우량기업부 to 벤처기업부) with a specified effective date. It does not contain financial data, management changes, voting results, or any detailed report content. It is a regulatory announcement about an internal classification change. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a statutory insider report filed by an executive (“임원ㆍ주요주주 특정증권등 소유상황보고서”) detailing personal share ownership and changes in holdings, submitted to the Financial Supervisory Commission and the Korea Exchange. This matches the definition for Director’s Dealing (DIRS), an insider transaction report by company directors/executives.
2026-04-08 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.